How inclusive are cell lines in preclinical engineered cancer models?
Diverse factors contribute to significant and dire disparities in cancer risk and treatment outcomes. To address this, there was a call for inclusion of sex as a biological variable, which resulted in more instances of careful inclusion of sex in preclinical studies of cancer. Another variable in ca...
Main Author: | Shreya Raghavan |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2022-05-01
|
Series: | Disease Models & Mechanisms |
Online Access: | http://dmm.biologists.org/content/15/5/dmm049520 |
Similar Items
-
Characterization of human follicular thyroid cancer cell lines in preclinical mouse models
by: Ashley N Reeb, et al.
Published: (2016-04-01) -
Preclinical Models of Follicular Cell-Derived Thyroid Cancer: An Overview from Cancer Cell Lines to Mouse Models
by: Min Ji Jeon, et al.
Published: (2022-12-01) -
PSMA-specific CAR-engineered T cells eradicate disseminated prostate cancer in preclinical models.
by: Gaia Zuccolotto, et al.
Published: (2014-01-01) -
Integrated cancer tissue engineering models for precision medicine.
by: Michael E Bregenzer, et al.
Published: (2019-01-01) -
PRECLINICAL MOUSE MODELS IN ADOPTIVE CELL THERAPIES OF CANCER
by: Uroš Rajčević, et al.
Published: (2022-12-01)